Next Science Ltd (OTCPK:NXSCF)
$ 0.1772 0 (0%) Market Cap: 48.59 Mil Enterprise Value: 40.27 Mil PE Ratio: 0 PB Ratio: 3.79 GF Score: 52/100

Full Year 2020 Next Science Ltd Earnings Call Transcript

Feb 23, 2021 / 03:00AM GMT
Release Date Price: $1.07
Operator

Thank you for standing by, and welcome to the Next Science Limited 2020 Full Year Results Conference Call. (Operator Instructions)

I would now like to hand the conference over to Ms. Judith Mitchell, Managing Director. Please go ahead.

Judith Mitchell
Next Science Limited - MD, CEO & Director

Good afternoon, and thank you for joining the Next Science full year 2020 results call. We've released a new PowerPoint deck to the ASX that we'll be using today as part of the presentation, and we'll start on Slide 2.

As you know, Next Science is a company that has unique technology platforms that allow the dispersion of biofilm and the elimination of bacteria, virus and fungus that can be thriving beneath that biofilm. Our proprietary technology Xbio works physically on the biofilm and the bacteria. So our products are currently creams, gels and washes. We're the only company in the world with approved products that resolve biofilm-based infections in humans. Over 150,000 patients have now benefited from treatment of our Xbio products, and

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot